The revenue from growth market formulations of Aurobindo Pharma Limited for fiscal year 2024 was over 25 billion Indian rupees. This revenue grew by over 29 percent from financial year 2023 to 2024 owing to the increased sales in Canada, and China.
Revenue from growth market formulations by Aurobindo Pharma Limited from financial year 2013 to 2024
(in billion Indian rupees)
According to Aurobindo Pharma Limited, growth markets represent the emerging markets like Brazil, South Africa, Ukraine, and Mexico, with a future focus on expansion into other selective markets in Asia Pacific, Africa and Middle East
India's financial year begins in April and ends in March. For example, FY 2024 started in April 2023 and ended in March 2024.
One Indian rupee is equal to 0.011 euros and 0.012 dollars (as of October 2024).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Aurobindo Pharma. (August 2, 2024). Revenue from growth market formulations by Aurobindo Pharma Limited from financial year 2013 to 2024 (in billion Indian rupees) [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/996275/india-aurobindo-pharma-growth-market-formulations-revenue/
Aurobindo Pharma. "Revenue from growth market formulations by Aurobindo Pharma Limited from financial year 2013 to 2024 (in billion Indian rupees)." Chart. August 2, 2024. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/996275/india-aurobindo-pharma-growth-market-formulations-revenue/
Aurobindo Pharma. (2024). Revenue from growth market formulations by Aurobindo Pharma Limited from financial year 2013 to 2024 (in billion Indian rupees). Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/996275/india-aurobindo-pharma-growth-market-formulations-revenue/
Aurobindo Pharma. "Revenue from Growth Market Formulations by Aurobindo Pharma Limited from Financial Year 2013 to 2024 (in Billion Indian Rupees)." Statista, Statista Inc., 2 Aug 2024, https://www-statista-com.ezproxy.canberra.edu.au/statistics/996275/india-aurobindo-pharma-growth-market-formulations-revenue/
Aurobindo Pharma, Revenue from growth market formulations by Aurobindo Pharma Limited from financial year 2013 to 2024 (in billion Indian rupees) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/996275/india-aurobindo-pharma-growth-market-formulations-revenue/ (last visited November 10, 2024)
Revenue from growth market formulations by Aurobindo Pharma Limited from financial year 2013 to 2024 (in billion Indian rupees) [Graph], Aurobindo Pharma, August 2, 2024. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/996275/india-aurobindo-pharma-growth-market-formulations-revenue/
